Literature DB >> 25765876

Geriatric assessment-identified deficits in older cancer patients with normal performance status.

Trevor A Jolly1, Allison M Deal2, Kirsten A Nyrop2, Grant R Williams2, Mackenzi Pergolotti2, William A Wood2, Shani M Alston2, Brittaney-Belle E Gordon2, Samara A Dixon2, Susan G Moore2, W Chris Taylor2, Michael Messino2, Hyman B Muss2.   

Abstract

BACKGROUND: We investigated whether a brief geriatric assessment (GA) would identify important patient deficits that could affect treatment tolerance and care outcomes within a sample of older cancer patients rated as functionally normal (80%-100%) on the Karnofsky performance status (KPS) scale.
METHODS: Cancer patients aged ≥65 years were assessed using a brief GA that included both professionally and patient-scored KPS and measures of comorbidity, polypharmacy, cognition, function, nutrition, and psychosocial status. Data were analyzed using descriptive statistics and multivariable logistic regression.
RESULTS: The sample included 984 patients: mean age was 73 years (range: 65-99 years), 74% were female, and 89% were white. GA was conducted before (23%), during (41%), or after (36%) treatment. Overall, 54% had a breast cancer diagnosis (n = 528), and 46% (n = 456) had cancers at other sites. Moreover, 81% of participants (n = 796) had both professionally and self-rated KPS ≥80, defined as functionally normal, and those patients are the focus of analysis. In this subsample, 550 (69%) had at least 1 GA-identified deficit, 222 (28%) had 1 deficit, 140 (18%) had 2 deficits, and 188 (24%) had ≥3 deficits. Specifically, 43% reported taking ≥9 medications daily, 28% had decreased social activity, 25% had ≥4 comorbidities, 23% had ≥1 impairment in instrumental activities of daily living, 18% had a Timed Up and Go time ≥14 seconds, 18% had ≥5% unintentional weight loss, and 12% had a Mental Health Index score ≤76.
CONCLUSION: Within this sample of older cancer patients who were rated as functionally normal by KPS, GA identified important deficits that could affect treatment tolerance and outcomes. ©AlphaMed Press.

Entities:  

Keywords:  Cancer; Geriatric assessment; Older; Performance status

Mesh:

Year:  2015        PMID: 25765876      PMCID: PMC4391761          DOI: 10.1634/theoncologist.2014-0247

Source DB:  PubMed          Journal:  Oncologist        ISSN: 1083-7159


  50 in total

1.  Race/ethnicity and the receipt of watchful waiting for the initial management of prostate cancer.

Authors:  Vickie L Shavers; Martin L Brown; Arnold L Potosky; Carrie N Klabunde; W W Davis; Judd W Moul; Angela Fahey
Journal:  J Gen Intern Med       Date:  2004-02       Impact factor: 5.128

2.  Assessment of health status in elderly patients with cancer.

Authors:  Joanna Kaźmierska
Journal:  Rep Pract Oncol Radiother       Date:  2012-08-09

3.  Comorbidity and functional status are independent in older cancer patients.

Authors:  M Extermann; J Overcash; G H Lyman; J Parr; L Balducci
Journal:  J Clin Oncol       Date:  1998-04       Impact factor: 44.544

4.  Implementing a geriatric assessment in cooperative group clinical cancer trials: CALGB 360401.

Authors:  Arti Hurria; Constance T Cirrincione; Hyman B Muss; Alice B Kornblith; William Barry; Andrew S Artz; Linda Schmieder; Rafat Ansari; William P Tew; Douglas Weckstein; Jeffrey Kirshner; Kayo Togawa; Kurt Hansen; Vani Katheria; Richard Stone; Ilene Galinsky; John Postiglione; Harvey Jay Cohen
Journal:  J Clin Oncol       Date:  2011-02-28       Impact factor: 44.544

5.  Frailty in older adults: evidence for a phenotype.

Authors:  L P Fried; C M Tangen; J Walston; A B Newman; C Hirsch; J Gottdiener; T Seeman; R Tracy; W J Kop; G Burke; M A McBurnie
Journal:  J Gerontol A Biol Sci Med Sci       Date:  2001-03       Impact factor: 6.053

6.  Predictors of early death risk in older patients treated with first-line chemotherapy for cancer.

Authors:  Pierre Soubeyran; Marianne Fonck; Christèle Blanc-Bisson; Jean-Frédéric Blanc; Joël Ceccaldi; Cécile Mertens; Yves Imbert; Laurent Cany; Luc Vogt; Jerôme Dauba; Francis Andriamampionona; Nadine Houédé; Anne Floquet; Francois Chomy; Véronique Brouste; Alain Ravaud; Carine Bellera; Muriel Rainfray
Journal:  J Clin Oncol       Date:  2012-04-16       Impact factor: 44.544

7.  Screening for mood and anxiety disorders with the five-item, the three-item, and the two-item Mental Health Inventory.

Authors:  Pim Cuijpers; Niels Smits; Tara Donker; Margreet ten Have; Ron de Graaf
Journal:  Psychiatry Res       Date:  2009-01-29       Impact factor: 3.222

8.  Should patient-rated performance status affect treatment decisions in advanced lung cancer?

Authors:  Esther Dajczman; Goulnar Kasymjanova; Harvey Kreisman; Nelda Swinton; Carmela Pepe; David Small
Journal:  J Thorac Oncol       Date:  2008-10       Impact factor: 15.609

9.  Prospective evaluation of prognostic variables from patient-completed questionnaires. North Central Cancer Treatment Group.

Authors:  C L Loprinzi; J A Laurie; H S Wieand; J E Krook; P J Novotny; J W Kugler; J Bartel; M Law; M Bateman; N E Klatt
Journal:  J Clin Oncol       Date:  1994-03       Impact factor: 44.544

Review 10.  Comprehensive geriatric assessment in oncology.

Authors:  Supriya G Mohile; Allison Magnuson
Journal:  Interdiscip Top Gerontol       Date:  2013-01-17
View more
  70 in total

Review 1.  Immunotherapy in Older Adults with Cancer.

Authors:  Richard Curtis Godby; Douglas B Johnson; Grant R Williams
Journal:  Curr Oncol Rep       Date:  2019-05-07       Impact factor: 5.075

2.  Variability of performance status assessment between patients with hematologic malignancies and their physicians.

Authors:  Alexis D Leal; Cristine Allmer; Matthew J Maurer; Tait D Shanafelt; James R Cerhan; Brian K Link; Carrie A Thompson
Journal:  Leuk Lymphoma       Date:  2017-07-18

3.  Distinct Physical Function Profiles in Older Adults Receiving Cancer Chemotherapy.

Authors:  Christine Miaskowski; Melisa L Wong; Bruce A Cooper; Judy Mastick; Steven M Paul; Katherine Possin; Michael Steinman; Janine Cataldo; Laura B Dunn; Christine Ritchie
Journal:  J Pain Symptom Manage       Date:  2017-07-15       Impact factor: 3.612

Review 4.  Embracing the complexity: Older adults with cancer-related cognitive decline-A Young International Society of Geriatric Oncology position paper.

Authors:  Mackenzi Pergolotti; Nicolò Matteo Luca Battisti; Lynne Padgett; Alix G Sleight; Maya Abdallah; Robin Newman; Kathleen Van Dyk; Kelley R Covington; Grant R Williams; Frederiek van den Bos; YaoYao Pollock; Elizabeth A Salerno; Allison Magnuson; Isabella F Gattás-Vernaglia; Tim A Ahles
Journal:  J Geriatr Oncol       Date:  2019-10-14       Impact factor: 3.599

5.  A Randomized Trial of Real-Time Geriatric Assessment Reporting in Nonelectively Hospitalized Older Adults with Cancer.

Authors:  Trevor A Jolly; Allison M Deal; Caroline Mariano; Nicole Markowski; Sharanda Kirk; Max S Perlmutt; Franklin Jones; Suel Ki Choi; Kirsten A Nyrop; Jan Busby-Whitehead; Hyman Muss
Journal:  Oncologist       Date:  2020-01-27

Review 6.  Hepatocellular carcinoma in older adults: A comprehensive review by Young International Society of Geriatric Oncology.

Authors:  Sukeshi Patel Arora; Gabor Liposits; Susan Caird; Richard F Dunne; Gordon Taylor Moffat; David Okonji; Maria Grazia Rodriquenz; Divyanshu Dua; Efrat Dotan
Journal:  J Geriatr Oncol       Date:  2019-11-06       Impact factor: 3.599

7.  Is "Geriatric" Assessment Just for Older Patients?

Authors:  Gabriel F P Aleixo; Seul Ki Choi; Alyssa J Tan; Kirsten A Nyrop; Alyson M Deal; William A Wood; Trevor A Jolly; Hyman B Muss
Journal:  Oncologist       Date:  2019-09-13

8.  Co-occurrence of decrements in physical and cognitive function is common in older oncology patients receiving chemotherapy.

Authors:  Inger Utne; Bruce A Cooper; Christine Ritchie; Melisa Wong; Laura B Dunn; Borghild Loyland; Ellen Karine Grov; Marilyn J Hammer; Steven M Paul; Jon D Levine; Yvette P Conley; Kord M Kober; Christine Miaskowski
Journal:  Eur J Oncol Nurs       Date:  2020-08-03       Impact factor: 2.398

9.  Chemotherapy Toxicity Risk Score for Treatment Decisions in Older Adults with Advanced Solid Tumors.

Authors:  Tomohiro F Nishijima; Allison M Deal; Grant R Williams; Hanna K Sanoff; Kirsten A Nyrop; Hyman B Muss
Journal:  Oncologist       Date:  2018-01-25

10.  A randomized controlled trial of outpatient CAncer REhabilitation for older adults: The CARE Program.

Authors:  Mackenzi Pergolotti; Allison M Deal; Grant R Williams; Ashley L Bryant; Bryce B Reeve; Hyman B Muss
Journal:  Contemp Clin Trials       Date:  2015-08-04       Impact factor: 2.226

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.